- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/57 - IFN-gamma
Patent holdings for IPC class C07K 14/57
Total number of patents in this class: 237
10-year publication summary
|
14
|
13
|
21
|
23
|
23
|
18
|
25
|
18
|
23
|
11
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 20778 |
9 |
| Innovative Cellular Therapeutics Holdings, Ltd. | 76 |
8 |
| Rutgers, The State University of New Jersey | 1972 |
7 |
| The Brigham and Women's Hospital, Inc. | 2286 |
5 |
| CytomX Therapeutics, Inc. | 232 |
5 |
| Universiteit Gent | 1406 |
5 |
| Vib VZW | 908 |
5 |
| Werewolf Therapeutics, Inc. | 65 |
5 |
| The Board of Trustees of the Leland Stanford Junior University | 6656 |
4 |
| Bolder Biotechnology, Inc. | 14 |
4 |
| Lonza Sales AG | 127 |
4 |
| Tilt Biotherapeutics Oy | 31 |
4 |
| Innovative Cellular Therapeutics Inc. | 61 |
4 |
| Immunowake Inc. | 12 |
4 |
| Orionis Biosciences BV | 81 |
4 |
| Hoffmann-La Roche Inc. | 3796 |
3 |
| Massachusetts Institute of Technology | 10254 |
3 |
| Agency for Science, Technology and Research | 3736 |
3 |
| Immatics Biotechnologies GmbH | 1126 |
3 |
| The University of Western Australia | 199 |
3 |
| Other owners | 145 |